Importance and Involvement of Imidazole Structure in Current and Future Therapy
Molecules · 2026
DOI: 10.3390/molecules31030423 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Molecules, 2026. Verfasst von Alexandra Pavel Burlacu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Research Centre in the Medical-Pharmaceutical Field, Faculty of Medicine and Pharmacy, "Dunarea de Jos" University of Galati, 35 AL Cuza Street, 8000…. Hauptthemen laut MEDLINE: Imidazoles, Antineoplastic Agents, Neoplasms. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 147 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: "Dunărea de Jos University of Galați", project type: "Internal grants to support university research activities", Dunărea de Jos University of Galați.
Abstract (Originalsprache)
Imidazole is, from a structural point of view, a heterocycle consisting of three C atoms and two N atoms, belonging to the class of diazoles, having two N atoms at the first and third positions in the aromatic ring. Being a polar and ionizable aromatic compound, it has the role of improving the pharmacological properties of lead molecules, thus being used to optimize their solubility and bioavailability. Imidazole is a constituent of many important biological compounds, like histidine, histamine, and purine compounds, the most widespread heterocyclic compound in nature. In current practice, substituted imidazole derivatives play a major role in antifungal, antibacterial, anti-inflammatory, CNS active compounds, antiprotozoal, as well as anticancer therapy. Thus, imidazole derivatives have demonstrated significant anticancer activities by inhibiting the key metabolic pathways essential for tumor cell growth and survival. Nitroimidazoles, for instance, have been employed as hypoxia-directed therapeutic agents, targeting oxygen-deprived tumor tissues, while mercaptopurine derivatives are well-established in oncological treatments. Structural modifications of the imidazole nucleus have led to the novel compounds exhibiting increased selective cytotoxicity against cancer cells, while sparing normal healthy cells. In accordance with what has been stated, this review highlights recent research on the medicinal and pharmaceutical interest of novel imidazole derivatives, emphasizing their potential in the development of new drugs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Research Centre in the Medical-Pharmaceutical Field, Faculty of Medicine and Pharmacy, "Dunarea de Jos" University of Galati, 35 AL Cuza Street, 800010 Galati, Romania.
- Department of II Pharmaceutical Science, Faculty of Pharmacy, Grigore T. Popa University of Medicine and Pharmacy Iasi, 700115 Iași, Romania.
- Department of Pharmaceutical Chemistry, "Iuliu Hațieganu" University of Medicine and Pharmacy, 41 Victor Babeș Street, 400012 Cluj-Napoca, Romania.
- Department of Pharmacognosy, Faculty of Pharmacy, "Iuliu Hațieganu" University of Medicine and Pharmacy, Ion Creangă Street 12, 400010 Cluj-Napoca, Romania.
ORCID-Profile: Maria Drăgan, Ilioara Oniga, Elena-Lăcrămioara Lisă, Oana-Maria Dragostin
Förderung
- "Dunărea de Jos University of Galați", project type: "Internal grants to support university research activities"
- Dunărea de Jos University of Galați
Zitieren
APA
Burlacu, A. P., Drăgan, M., Oniga, O., Matei, M. N., Oniga, I., Lisă, E. L., Stefan, C. S., & Dragostin, O. M. (2026). Importance and Involvement of Imidazole Structure in Current and Future Therapy. Molecules. https://doi.org/10.3390/molecules31030423
Vancouver
Burlacu AP, Drăgan M, Oniga O, Matei MN, Oniga I, Lisă EL, et al. Importance and Involvement of Imidazole Structure in Current and Future Therapy. Molecules. 2026. doi:10.3390/molecules31030423
BibTeX
@article{Burlacu2026,
author = {Burlacu, Alexandra Pavel and Drăgan, Maria and Oniga, Ovidiu and Matei, Mădălina Nicoleta and Oniga, Ilioara and Lisă, Elena-Lăcrămioara and Stefan, Claudia-Simona and Dragostin, Oana-Maria},
title = {Importance and Involvement of Imidazole Structure in Current and Future Therapy},
journal = {Molecules},
year = {2026},
doi = {10.3390/molecules31030423}
}
EUVIMED